USPTO issues notice of allowance to Vermillion's breast cancer biomarkers
Vermillion, a molecular diagnostics company, today announced that the United States Patent and Trademark Office has issued a notice of allowance for a patent entitled "Biomarkers for breast cancer" to the Company.